Content

Welcome to the CJU website » LOG IN

Details

POINT: Its never too soon
University of Maryland Greenebaum Cancer Center, School of Medicine, Baltimore,
Dec 2003 (Vol. 10, Issue 6, Pages( 2036 - 2037)

Abstract

Text-Size + 

  • A multidisciplinary approach to prostate cancer has become the rule and not the exception. Involving the entire team, which includes a medical oncologist, from the time of initial diagnosis is optimal. This facilitates maximal patient education regarding treatment options and enhances informed decision making. A coordinated approach also promotes enrollment on clinical trials, which are often, multimodality, especially in high-risk early stage prostate cancer. Integrated therapeutic strategies throughout the patient's disease course can improve both patient care and satisfaction

Current Issue

October 2020, Vol.27 No.5
canadian journal of urology